Literature DB >> 26056357

Peto's paradox and human cancers.

Robert Noble1, Oliver Kaltz1, Michael E Hochberg2.   

Abstract

Peto's paradox is the lack of the expected trend in cancer incidence as a function of body size and lifespan across species. The leading hypothesis to explain this pattern is natural selection for differential cancer prevention in larger, longer lived species. We evaluate whether a similar effect exists within species, specifically humans. We begin by reanalysing a recently published dataset to separate the effects of stem cell number and replication rate, and show that each has an independent effect on cancer risk. When considering the lifetime number of stem cell divisions in an extended dataset, and removing cases associated with other diseases or carcinogens, we find that lifetime cancer risk per tissue saturates at approximately 0.3-1.3% for the types considered. We further demonstrate that grouping by anatomical site explains most of the remaining variation. Our results indicate that cancer risk depends not only on the number of stem cell divisions but varies enormously (approx. 10 000 times) depending on anatomical site. We conclude that variation in risk of human cancer types is analogous to the paradoxical lack of variation in cancer incidence among animal species and may likewise be understood as a result of evolution by natural selection.
© 2015 The Author(s) Published by the Royal Society. All rights reserved.

Entities:  

Keywords:  Peto's paradox; cancer; carcinogenesis; disease; stem cells; ‘bad luck’ mutations

Mesh:

Year:  2015        PMID: 26056357      PMCID: PMC4581036          DOI: 10.1098/rstb.2015.0104

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  19 in total

Review 1.  Basal cell carcinoma.

Authors:  C S M Wong; R C Strange; J T Lear
Journal:  BMJ       Date:  2003-10-04

2.  Bad luck and cancer: Does evolution spin the wheel of fortune?

Authors:  Benjamin Roche; Beata Ujvari; Frédéric Thomas
Journal:  Bioessays       Date:  2015-03-20       Impact factor: 4.345

Review 3.  Lineage selection and the evolution of multistage carcinogenesis.

Authors:  L Nunney
Journal:  Proc Biol Sci       Date:  1999-03-07       Impact factor: 5.349

4.  Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women.

Authors:  Geoffrey C Kabat; Matthew L Anderson; Moonseong Heo; H Dean Hosgood; Victor Kamensky; Jennifer W Bea; Lifang Hou; Dorothy S Lane; Jean Wactawski-Wende; JoAnn E Manson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-25       Impact factor: 4.254

5.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

Review 6.  Cerebellum development and medulloblastoma.

Authors:  Martine F Roussel; Mary E Hatten
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 7.  Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?

Authors:  J DeGregori
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

8.  Somatic stem cells and the kinetics of mutagenesis and carcinogenesis.

Authors:  John Cairns
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

9.  Are cell number and cell proliferation risk factors for cancer?

Authors:  D Albanes; M Winick
Journal:  J Natl Cancer Inst       Date:  1988-07-20       Impact factor: 13.506

10.  Towards cancer-aware life-history modelling.

Authors:  Hanna Kokko; Michael E Hochberg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

View more
  21 in total

Review 1.  Big Bang Tumor Growth and Clonal Evolution.

Authors:  Ruping Sun; Zheng Hu; Christina Curtis
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  A population genetics perspective on the determinants of intra-tumor heterogeneity.

Authors:  Zheng Hu; Ruping Sun; Christina Curtis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-06       Impact factor: 10.680

Review 3.  Peto's paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer.

Authors:  L Nunney; B Muir
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 4.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

5.  Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations?

Authors:  Aaron L Sarver; Kelly M Makielski; Taylor A DePauw; Ashley J Schulte; Jaime F Modiano
Journal:  Aging Cancer       Date:  2022-02-23

6.  Size matters: height, cell number and a person's risk of cancer.

Authors:  Leonard Nunney
Journal:  Proc Biol Sci       Date:  2018-10-24       Impact factor: 5.349

7.  Peto's paradox and the promise of comparative oncology.

Authors:  Leonard Nunney; Carlo C Maley; Matthew Breen; Michael E Hochberg; Joshua D Schiffman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

8.  All's well that ends well: why large species have short telomeres.

Authors:  Rosa Ana Risques; Daniel E L Promislow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-05       Impact factor: 6.237

9.  Determining cancer risk: the evolutionary multistage model or total stem cell divisions?

Authors:  Leonard Nunney; Kevin Thai
Journal:  Proc Biol Sci       Date:  2020-12-16       Impact factor: 5.349

10.  Towards cancer-aware life-history modelling.

Authors:  Hanna Kokko; Michael E Hochberg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.